IRIS Accounts Production v23.3.0.418 06601927 Board of Directors 1.1.23 31.12.23 31.12.23 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh066019272022-12-31066019272023-12-31066019272023-01-012023-12-31066019272021-12-31066019272022-01-012022-12-31066019272022-12-3106601927ns10:Originalns15:EnglandWales2023-01-012023-12-3106601927ns14:PoundSterlingns10:Original2023-01-012023-12-3106601927ns10:Originalns10:Director12023-01-012023-12-3106601927ns10:Original2023-01-012023-12-3106601927ns10:Original2023-12-3106601927ns10:Originalns10:PrivateLimitedCompanyLtd2023-01-012023-12-3106601927ns10:Originalns10:SmallEntities2023-01-012023-12-3106601927ns10:Originalns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3106601927ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3106601927ns10:SmallCompaniesRegimeForAccountsns10:Original2023-01-012023-12-3106601927ns10:Originalns10:FullAccounts2023-01-012023-12-3106601927ns10:Original2022-01-012022-12-3106601927ns10:Originalns10:Director32023-01-012023-12-3106601927ns10:Originalns10:Director42023-01-012023-12-3106601927ns10:Originalns10:RegisteredOffice2023-01-012023-12-3106601927ns10:Original2022-12-3106601927ns10:Originalns5:CurrentFinancialInstruments2023-12-3106601927ns10:Originalns5:CurrentFinancialInstruments2022-12-3106601927ns5:ShareCapitalns10:Original2023-12-3106601927ns5:ShareCapitalns10:Original2022-12-3106601927ns10:Originalns5:SharePremium2023-12-3106601927ns10:Originalns5:SharePremium2022-12-3106601927ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-12-3106601927ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3106601927ns10:Originalns5:ComputerEquipment2023-01-012023-12-3106601927ns10:Originalns5:ComputerEquipment2022-12-3106601927ns10:Originalns5:ComputerEquipment2023-12-3106601927ns10:Originalns5:ComputerEquipment2022-12-3106601927ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3106601927ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-31
REGISTERED NUMBER: 06601927 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2023

for

Xycare Limited

Xycare Limited (Registered number: 06601927)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Xycare Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: Dr I Rubin
R McGovern
L Bailey





REGISTERED OFFICE: Lytchett House
13 Freeland Park
Wareham Road
Poole
Dorset
BH16 6FA





REGISTERED NUMBER: 06601927 (England and Wales)

Xycare Limited (Registered number: 06601927)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,100 1,113

CURRENT ASSETS
Debtors 5 28,780 48,918
Cash at bank 16,712 49,896
45,492 98,814
CREDITORS
Amounts falling due within one year 6 24,329 24,765
NET CURRENT ASSETS 21,163 74,049
TOTAL ASSETS LESS CURRENT
LIABILITIES

22,263

75,162

PROVISIONS FOR LIABILITIES - 211
NET ASSETS 22,263 74,951

CAPITAL AND RESERVES
Called up share capital 149 149
Share premium 29,962 29,962
Retained earnings (7,848 ) 44,840
22,263 74,951

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Xycare Limited (Registered number: 06601927)

Balance Sheet - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 February 2024 and were signed on its behalf by:





Dr I Rubin - Director


Xycare Limited (Registered number: 06601927)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Xycare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

Xycare Limited (Registered number: 06601927)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 January 2023 1,670
Additions 816
At 31 December 2023 2,486
DEPRECIATION
At 1 January 2023 557
Charge for year 829
At 31 December 2023 1,386
NET BOOK VALUE
At 31 December 2023 1,100
At 31 December 2022 1,113

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 14,800 36,200
Tax 6,162 -
VAT 3,507 3,809
Called up share capital not paid 98 98
Prepayments 4,213 8,811
28,780 48,918

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade creditors 16,953 17,389
Tax 6,162 6,162
Other creditors 864 864
Accrued expenses 350 350
24,329 24,765

7. ULTIMATE CONTROLLING PARTY

The controlling party is Dr I Rubin.